pre-miRNA Information
pre-miRNA hsa-mir-3622a   
Genomic Coordinates chr8: 27701677 - 27701759
Description Homo sapiens miR-3622a stem-loop
Comment None
RNA Secondary Structure

Mature miRNA Information
Mature miRNA hsa-miR-3622a-5p
Sequence 14| CAGGCACGGGAGCUCAGGUGAG |35
Evidence Experimental
Experiments Illumina
Editing Events in miRNAs
Modification Type Position on miR Chromosome DNA Strand Genomic Position (hg38) List of PMIDs Variant details
A-to-I 2 8 + 27701691 29233923 MiREDiBase
A-to-I 6 8 + 27701695 29233923 MiREDiBase
A-to-I 16 8 + 27701705 28550310, 29233923 MiREDiBase
A-to-I 21 8 + 27701710 29233923 MiREDiBase
SNPs in miRNA
Mutant ID Mutant Position Mutant Source
rs551845360 1 dbSNP
rs946438979 3 dbSNP
rs1044808718 7 dbSNP
rs66683138 8 dbSNP
rs1157333896 10 dbSNP
rs1439657384 12 dbSNP
rs530939348 17 dbSNP
rs1232922758 20 dbSNP
rs1448152954 22 dbSNP
Putative Targets

miRNA Expression profile
Human miRNA Tissue Atlas
miRNAs in Extracellular Vesicles
Circulating MicroRNA Expression Profiling
Gene Information
Gene Symbol GABRB1   
Synonyms EIEE45
Description gamma-aminobutyric acid type A receptor beta1 subunit
Transcript NM_000812   
Expression
Putative miRNA Targets on GABRB1
3'UTR of GABRB1
(miRNA target sites are highlighted)
>GABRB1|NM_000812|3'UTR
   1 GGTCTGTTCTAATGGTTCCATTTAGACTACTTTCCTCTTCTATTGTTTTTTAACCTTACAGGTCCCCAACAGCGATACTG
  81 CTGTTTCTCGAGGTAAGAGATTCAGCCATCCAATTGGTTTTAGGTCTTGCATATCAGTTTTATTACTGCACCATGTTTAC
 161 TTCAAAAAGACAAAACAAAAAAAAAATTATTTTTCCAGTCTACCGTGGTCCAGGTTATCAGCTCTTTAAGAGCTCTATTA
 241 ATTGCCATGTTTACAAACAAACACAAAGAGAGAAGTTAGACAGGTAGATCTTTAGCAGTCTTTTCTAGTTTCCCTGGATT
 321 TCACTGATTTATTTTTTAGGGAAAATGAAAAGAGGACCTTGCTGTCCGCCTGCACTGCTTCCTGGTAAACTATAACAAAC
 401 TTATGCTGCCAAAAAAAAAAAAAAAAA
Target sites Provided by authors   Predicted by miRanda    DRVs    SNPs    DRVs & SNPs
miRNA-target interactions
(Predicted by miRanda)
ID Duplex structure Position Score MFE
1
miRNA  3' gaguggaCUCGAG-GGCA--CGGAc 5'
                 || ||: |:||  |||| 
Target 5' aaaagagGACCTTGCTGTCCGCCTg 3'
348 - 372 99.00 -17.40
2
miRNA  3' gaguggacUC-GAGGGCACggac 5'
                  || || |||||    
Target 5' atttttccAGTCTACCGTGgtcc 3'
189 - 211 94.00 -10.60
3
miRNA  3' gaGUGGACUC---GAGGGCACGGAc 5'
            || | | |   || |:|| :|| 
Target 5' ccCAACAGCGATACTGCTGTTTCTc 3'
65 - 89 92.00 -10.50
DRVs in gene 3'UTRs
Mutant ID Mutant Position Mutant Source
COSN30188073 3 COSMIC
COSN31600213 5 COSMIC
COSN29284499 7 COSMIC
COSN31501200 14 COSMIC
COSN30183540 19 COSMIC
COSN30514083 25 COSMIC
COSN30152781 26 COSMIC
COSN30102322 38 COSMIC
COSN30450894 41 COSMIC
COSN18729136 45 COSMIC
COSN30146734 67 COSMIC
COSN14113683 69 COSMIC
COSN26976991 74 COSMIC
COSN18718284 75 COSMIC
COSN30186276 79 COSMIC
COSN31612422 79 COSMIC
COSN1297839 85 COSMIC
COSN24383763 90 COSMIC
COSN19709404 91 COSMIC
COSN508369 97 COSMIC
COSN31501623 136 COSMIC
COSN28868144 187 COSMIC
COSN32064928 205 COSMIC
COSN20100028 305 COSMIC
SNPs in gene 3'UTRs
Mutant ID Mutant Position Mutant Source
rs1471788158 1 dbSNP
rs776456940 2 dbSNP
rs1455729676 5 dbSNP
rs1339197576 7 dbSNP
rs745503672 8 dbSNP
rs1447756614 10 dbSNP
rs1282852852 12 dbSNP
rs769397165 14 dbSNP
rs774995285 16 dbSNP
rs373376360 21 dbSNP
rs769161799 23 dbSNP
rs1205033007 30 dbSNP
rs775033184 39 dbSNP
rs762453818 43 dbSNP
rs1185130440 44 dbSNP
rs376352619 45 dbSNP
rs1465023387 46 dbSNP
rs750877808 52 dbSNP
rs1464885482 55 dbSNP
rs1272951018 60 dbSNP
rs1329092137 63 dbSNP
rs544199293 69 dbSNP
rs1359099026 70 dbSNP
rs899694880 71 dbSNP
rs1036432184 75 dbSNP
rs553175666 79 dbSNP
rs997999417 88 dbSNP
rs1299846916 91 dbSNP
rs1436097864 96 dbSNP
rs762537059 98 dbSNP
rs1393974496 105 dbSNP
rs1324994702 109 dbSNP
rs1403369540 110 dbSNP
rs897903968 111 dbSNP
rs577415550 114 dbSNP
rs1474827414 130 dbSNP
rs1004502912 132 dbSNP
rs1189863306 144 dbSNP
rs1220012571 150 dbSNP
rs763675411 152 dbSNP
rs963346310 156 dbSNP
rs1453650700 159 dbSNP
rs570487863 164 dbSNP
rs1316975291 170 dbSNP
rs1197107518 172 dbSNP
rs1337947443 174 dbSNP
rs111359296 177 dbSNP
rs1276905715 177 dbSNP
rs1370594954 177 dbSNP
rs569240613 177 dbSNP
rs1281107055 180 dbSNP
rs1301489235 181 dbSNP
rs889382217 182 dbSNP
rs1332592106 185 dbSNP
rs1209948442 188 dbSNP
rs1409304057 189 dbSNP
rs192098838 205 dbSNP
rs1021867588 208 dbSNP
rs1034384807 215 dbSNP
rs1394139051 219 dbSNP
rs968402155 231 dbSNP
rs575157459 233 dbSNP
rs1194535350 238 dbSNP
rs1247664284 242 dbSNP
rs1181489737 244 dbSNP
rs993031570 263 dbSNP
rs1206009073 265 dbSNP
rs1476938820 266 dbSNP
rs10028945 271 dbSNP
rs1276847559 273 dbSNP
rs751183559 282 dbSNP
rs1345896389 283 dbSNP
rs1031465102 289 dbSNP
rs755405631 292 dbSNP
rs967665858 299 dbSNP
rs3832300 301 dbSNP
rs993076759 309 dbSNP
rs1409971412 312 dbSNP
rs1374338665 317 dbSNP
rs372181109 325 dbSNP
rs925641482 329 dbSNP
rs935638604 341 dbSNP
rs970397924 349 dbSNP
rs984076959 354 dbSNP
rs1471797505 356 dbSNP
rs1414924213 364 dbSNP
rs1298323744 368 dbSNP
rs1485597184 369 dbSNP
rs1235810128 372 dbSNP
rs1212280640 374 dbSNP
rs1443237080 376 dbSNP
rs147193608 379 dbSNP
rs1216348506 384 dbSNP
rs1290199411 385 dbSNP
rs1326806752 385 dbSNP
rs1228938376 387 dbSNP
rs1276251022 393 dbSNP
rs1300596825 394 dbSNP
rs1346143004 397 dbSNP
rs933698757 405 dbSNP
rs1317191714 409 dbSNP
rs1359421845 409 dbSNP
rs1277090594 410 dbSNP
rs1391309432 410 dbSNP
rs1491505846 410 dbSNP
rs1180682917 411 dbSNP
rs1209071008 411 dbSNP
rs1241810152 411 dbSNP
rs1269822795 411 dbSNP
rs1321104226 411 dbSNP
rs1378578012 411 dbSNP
rs1466371476 411 dbSNP
rs1491579356 411 dbSNP
rs59682924 411 dbSNP
rs1356511530 412 dbSNP
rs1218020899 413 dbSNP
rs1310447794 417 dbSNP
rs1229602614 421 dbSNP
rs1262509728 422 dbSNP
rs1379249583 422 dbSNP
rs562251554 423 dbSNP
rs1201193688 424 dbSNP
rs886903018 425 dbSNP
rs11731834 428 dbSNP
rs1348684133 428 dbSNP
rs1491044276 429 dbSNP
rs1248857360 430 dbSNP
rs1451587645 430 dbSNP
rs1491060750 430 dbSNP
rs909787910 430 dbSNP
Experimental Support 1 for Functional miRNA-Target Interaction
miRNA:Target ----
Validation Method
Conditions TZM-bl
Location of target site 3'UTR
Tools used in this research TargetScan , miRTarCLIP , Piranha
Original Description (Extracted from the article) ... PAR-CLIP data was present in GSM1462574. RNA binding protein: AGO2. Condition:TZM-bl ami BaL ...

- Whisnant AW; Bogerd HP; Flores O; Ho P; et al., 2013, mBio.

miRNA-target interactions (Provided by authors)
ID Duplex structure Position
1
miRNA  3' gaguggacucgaGGGCACGGAc 5'
                      | ||||||| 
Target 5' ------------CGCGUGCCUg 3'
1 - 10
Article - Whisnant AW; Bogerd HP; Flores O; Ho P; et al.
- mBio, 2013
UNLABELLED: The question of how HIV-1 interfaces with cellular microRNA (miRNA) biogenesis and effector mechanisms has been highly controversial. Here, we first used deep sequencing of small RNAs present in two different infected cell lines (TZM-bl and C8166) and two types of primary human cells (CD4(+) peripheral blood mononuclear cells [PBMCs] and macrophages) to unequivocally demonstrate that HIV-1 does not encode any viral miRNAs. Perhaps surprisingly, we also observed that infection of T cells by HIV-1 has only a modest effect on the expression of cellular miRNAs at early times after infection. Comprehensive analysis of miRNA binding to the HIV-1 genome using the photoactivatable ribonucleoside-induced cross-linking and immunoprecipitation (PAR-CLIP) technique revealed several binding sites for cellular miRNAs, a subset of which were shown to be capable of mediating miRNA-mediated repression of gene expression. However, the main finding from this analysis is that HIV-1 transcripts are largely refractory to miRNA binding, most probably due to extensive viral RNA secondary structure. Together, these data demonstrate that HIV-1 neither encodes viral miRNAs nor strongly influences cellular miRNA expression, at least early after infection, and imply that HIV-1 transcripts have evolved to avoid inhibition by preexisting cellular miRNAs by adopting extensive RNA secondary structures that occlude most potential miRNA binding sites. IMPORTANCE: MicroRNAs (miRNAs) are a ubiquitous class of small regulatory RNAs that serve as posttranscriptional regulators of gene expression. Previous work has suggested that HIV-1 might subvert the function of the cellular miRNA machinery by expressing viral miRNAs or by dramatically altering the level of cellular miRNA expression. Using very sensitive approaches, we now demonstrate that neither of these ideas is in fact correct. Moreover, HIV-1 transcripts appear to largely avoid regulation by cellular miRNAs by adopting an extensive RNA secondary structure that occludes the ability of cellular miRNAs to interact with viral mRNAs. Together, these data suggest that HIV-1, rather than seeking to control miRNA function in infected cells, has instead evolved a mechanism to become largely invisible to cellular miRNA effector mechanisms.
LinkOut: [PMID: 23592263]
CLIP-seq Support 1 for dataset GSM1462574
Method / RBP PAR-CLIP / AGO2
Cell line / Condition TZM-bl / TZM-bl ami BaL
Location of target site ENST00000295454.3 | 3UTR | CGCGUGCCUGUAGUC
Tools used in this analysis TargetScan, miRTarCLIP, and Piranha
Article / Accession Series PMID: 23592263 / GSE59944
CLIP-seq Viewer Link
MiRNA-Target Expression Profile
Dataset Pearson Correlation P-value for Pearson Correlation Spearman Correlation P-value for Spearman Correlation Samples Chart
MiRNA-Target Expression Profile (TCGA)
Tumor Pearson Correlation P-value for Pearson Correlation Spearman Correlation P-value for Spearman Correlation Samples Chart
THCA -0.572 0.07 -0.214 0.31 8 Click to see details
THCA -0.572 0.07 -0.214 0.31 8 Click to see details
THCA -0.572 0.07 -0.214 0.31 8 Click to see details
THCA -0.572 0.07 -0.214 0.31 8 Click to see details
THCA -0.572 0.07 -0.214 0.31 8 Click to see details
THCA -0.572 0.07 -0.214 0.31 8 Click to see details
THCA -0.572 0.07 -0.214 0.31 8 Click to see details
61 hsa-miR-3622a-5p Target Genes:
Functional analysis:
ID Target Description Validation methods
Strong evidence Less strong evidence
MIRT166678 ZSWIM6 zinc finger SWIM-type containing 6 2 2
MIRT452081 ATP6V0B ATPase H+ transporting V0 subunit b 2 2
MIRT457039 S1PR3 sphingosine-1-phosphate receptor 3 2 2
MIRT471975 NR3C1 nuclear receptor subfamily 3 group C member 1 2 2
MIRT474065 LMNB2 lamin B2 2 2
MIRT475862 H6PD hexose-6-phosphate dehydrogenase/glucose 1-dehydrogenase 2 2
MIRT476191 GOLGA8A golgin A8 family member A 2 2
MIRT476521 GABRB1 gamma-aminobutyric acid type A receptor beta1 subunit 2 2
MIRT483046 C15orf52 chromosome 15 open reading frame 52 2 4
MIRT495541 EIF3H eukaryotic translation initiation factor 3 subunit H 2 2
MIRT495892 CLOCK clock circadian regulator 2 2
MIRT495992 LTBP2 latent transforming growth factor beta binding protein 2 2 2
MIRT496001 EMP1 epithelial membrane protein 1 2 2
MIRT496208 PLEKHG2 pleckstrin homology and RhoGEF domain containing G2 2 2
MIRT496427 ACTRT3 actin related protein T3 2 2
MIRT496438 ZNF704 zinc finger protein 704 2 2
MIRT496473 SDE2 SDE2 telomere maintenance homolog 2 2
MIRT496555 TBX15 T-box 15 2 2
MIRT497202 CECR1 adenosine deaminase 2 2 2
MIRT507632 CREBZF CREB/ATF bZIP transcription factor 2 2
MIRT513377 MGAT4A mannosyl (alpha-1,3-)-glycoprotein beta-1,4-N-acetylglucosaminyltransferase, isozyme A 2 2
MIRT523460 GOLGA8J golgin A8 family member J 2 2
MIRT523465 GOLGA8I golgin A8 family member I, pseudogene 1 1
MIRT526049 GMDS GDP-mannose 4,6-dehydratase 2 2
MIRT533122 YIPF4 Yip1 domain family member 4 2 2
MIRT534183 SLC8A1 solute carrier family 8 member A1 2 2
MIRT556618 LCOR ligand dependent nuclear receptor corepressor 2 2
MIRT563361 WHSC1 nuclear receptor binding SET domain protein 2 2 2
MIRT563868 FAM206A family with sequence similarity 206 member A 2 2
MIRT564360 PPWD1 peptidylprolyl isomerase domain and WD repeat containing 1 2 2
MIRT564661 ZNF449 zinc finger protein 449 2 2
MIRT564805 ZBTB33 zinc finger and BTB domain containing 33 2 2
MIRT564867 ZBED3 zinc finger BED-type containing 3 2 2
MIRT565340 TMEM104 transmembrane protein 104 2 2
MIRT566439 PHF16 jade family PHD finger 3 2 2
MIRT567587 FCHSD2 FCH and double SH3 domains 2 2 2
MIRT569597 C3orf62 chromosome 3 open reading frame 62 2 2
MIRT569700 FMNL3 formin like 3 2 2
MIRT575957 Nanos1 nanos homolog 1 (Drosophila) 2 3
MIRT576516 Slc35e2 solute carrier family 35, member E2 2 2
MIRT608480 RRP36 ribosomal RNA processing 36 2 2
MIRT614335 NANOS1 nanos C2HC-type zinc finger 1 2 3
MIRT630816 ATAT1 alpha tubulin acetyltransferase 1 2 4
MIRT631708 C1QTNF6 C1q and TNF related 6 2 2
MIRT632369 SRRD SRR1 domain containing 2 2
MIRT633471 DSN1 DSN1 homolog, MIS12 kinetochore complex component 2 2
MIRT634478 PAFAH1B2 platelet activating factor acetylhydrolase 1b catalytic subunit 2 2 2
MIRT667336 MTHFD1L methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 1 like 2 2
MIRT667654 LFNG LFNG O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase 2 2
MIRT671046 SS18 SS18, nBAF chromatin remodeling complex subunit 2 2
MIRT672823 VEZT vezatin, adherens junctions transmembrane protein 2 2
MIRT673049 SGPL1 sphingosine-1-phosphate lyase 1 2 2
MIRT673435 APAF1 apoptotic peptidase activating factor 1 2 2
MIRT676096 DPP9 dipeptidyl peptidase 9 2 2
MIRT678059 RPL7L1 ribosomal protein L7 like 1 2 2
MIRT679783 GOLGA2 golgin A2 2 2
MIRT684219 C9orf64 chromosome 9 open reading frame 64 2 2
MIRT697642 WRN Werner syndrome RecQ like helicase 2 2
MIRT706595 C1RL complement C1r subcomponent like 2 2
MIRT706603 CCS copper chaperone for superoxide dismutase 2 2
MIRT717647 HLX H2.0 like homeobox 2 2
miRNA-Drug Resistance Associations
miRNA Drug Name CID NSC FDA Effect/Pattern Detection Method Level Phenotype Condition
hsa-mir-3622a Doxorubicin 31703 NSC123127 approved resistant High Hepatocellular Carcinoma cell line (HepG2)
hsa-mir-3622a Paclitaxel 36314 NSC125973 approved resistant cell line (W1)
hsa-miR-3622a-5p Paclitaxel 36314 NSC125973 approved resistant High Non-Small Cell Lung Cancer cell line (A549)
hsa-miR-3622a-5p Osimertinib 71496458 NSC779217 approved resistant cell line (PC9)
hsa-miR-3622a-5p Osimertinib 71496458 NSC779217 approved resistant cell line (HCC827)
hsa-miR-3622a-5p Cisplatin 5460033 NSC119875 approved sensitive cell line (A549)
hsa-miR-3622a-5p Gefitinib 123631 NSC715055 approved sensitive cell line (HCC827)
hsa-miR-3622a-5p Osimertinib 71496458 NSC779217 approved sensitive cell line (H1975)
hsa-miR-3622a-5p Cisplatin 5460033 NSC119875 approved sensitive cell line (MGC-803)
hsa-miR-3622a-5p Cisplatin 5460033 NSC119875 approved sensitive cell line (A549)
hsa-miR-3622a-5p Gemcitabine 60750 NSC613327 approved sensitive cell line (PANC-1) (1500 ng/ml)
hsa-miR-3622a-5p Gemcitabine 60750 NSC613327 approved sensitive cell line (PANC-1) (100 ng/ml)
hsa-miR-3622a-5p Gemcitabine 60750 NSC613327 approved sensitive cell line (Panc1-GR3)
hsa-miR-3622a-5p Cisplatin 5460033 NSC119875 approved sensitive cell line (A549)

Error report submission